Prospective applicability study of the new dengue classification system for clinical management in children

Pediatric Infectious Disease Journal

Volumn 33, Issue 9, 2014, Pages 933-935

  Lovera, Dolores ^a,b   Araya, Soraya ^a   Mesquita, Maria Jose ^a   Avalos, Cinthia ^a   Ledesma, Silvia ^a   Arbo, Antonio ^a,b  

^a Instituto de Medicina Tropical   (Paraguay)

^b UNIVERSIDAD NACIONAL DE ASUNCIÓN   (Paraguay)

Author keywords

Children; Dengue; Revised classification; Who classification

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DENGUE; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WORLD HEALTH ORGANIZATION; CLASSIFICATION; EPIDEMIC; PARAGUAY; PRACTICE GUIDELINE; PRESCHOOL CHILD; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; PARAGUAY; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; WORLD HEALTH ORGANIZATION;

EID: 84926141922     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000340     Document Type: Article

References (17)

1. Simmons C P, Farrar JJ, Nguyen v V, et al. Dengue. N Engl J Med. 2012;366:1423-1432.
2. Mark E, Beatty ME, Stone A, Fitzsimons DW et al. Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis. 2010;4:e890.
3. Rigau-Pérez JG. Severe dengue: the need for new case definitions. Lancet Infect Dis. 2006;6:297-302.
4. Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet. 2006;368:170-173.
5. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd ed. Geneva: WHO; 1997.
6. Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health. 2006;11:1238-1255.
7. WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. Geneva: WHO; 3y2009.
8. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet. 2000;355:1053-1059.
9. Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526-1538.
10. Levine MC, Klugman D, Teach SJ. Update on myocarditis in children. Curr Opin Pediatr 2010;22:278-83.
11. Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg. 2006;100:608-614.
12. Souza LJ, Alves JG, Nogueira RM, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1, 585 cases. Braz J Infect Dis. 2004;8:156-163.
13. Lee IK, Liu J W, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:221-226.
14. Araya S, Avalos C, Duarte M, et al. Clinical behavior of dengue in children in recent years in Paraguay. Rev Inst Med Trop. 2010;51:13-18
15. Alexander N, Balmaseda A, Coelho IC, et al.; European Union, World Health Organization (WHO-TDR) supported DENCO Study Group. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health. 2011;16:936-948.
16. Barniol J, Gaczkowski R, Barbato EV, et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis. 2011;11:106.
17. Basuki PS, Budiyanto, Puspitasari D, et al. Application of revised dengue classification criteria as a severity marker of dengue viral infection in Indonesia. Southeast Asian J Trop Med Public Health. 2010;41:1088-1094.